FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307038946> ?p ?o ?g. }

• W4307038946 endingPage "e203" @default.
• W4307038946 startingPage "e181" @default.
• W4307038946 abstract "Objectives Clodronate-liposome is used for depleting mononuclear phagocytes associated with ischemia-reperfusion injury. We hypothesized that administration of clodronate-liposome into the perfusate during ex vivo lung perfusion could reduce mononuclear phagocytes and attenuate ischemia-reperfusion injury. Methods First, the number of mononuclear phagocytes in flushed grafts (minimum cold ischemic time, 6-hour cold ischemic time, 15-hour cold ischemic time, and 18-hour cold ischemic time; n = 6 each) was determined using flow cytometry. Second, grafts (15-hour cold ischemic time) were allocated to control or clodronate (n = 5 each). In the clodronate group, clodronate-liposome is administered into the perfusate. After 4 hours of ex vivo lung perfusion, the number of mononuclear phagocytes in the perfusate and lung tissues was measured. Third, grafts (15-hour cold ischemic time) were allocated to control or clodronate (n = 6 each). After 4 hours of ex vivo lung perfusion, the left lungs were transplanted and reperfused for 2 hours. Lung function was evaluated, and samples were analyzed. Results First, mononuclear phagocytes remain in flushed grafts after prolonged cold ischemia. Second, the number of mononuclear phagocytes in lung tissues after ex vivo lung perfusion was significantly reduced in the clodronate group (P = .008). Third, lung compliance and vascular resistance during ex vivo lung perfusion were significantly improved in the clodronate group (P < .001 for both). Blood oxygenation and pulmonary edema were significantly improved in the clodronate group after 2 hours of reperfusion (P = .015 and P = .026, respectively). Histological findings showed reduced lung injury in the clodronate group (P = .013). Conclusions Administration of clodronate-liposome into the perfusate during ex vivo lung perfusion resulted in a significant reduction of mononuclear phagocytes in donor lungs, leading to attenuation of ischemia-reperfusion injury." @default.
• W4307038946 created "2022-10-23" @default.
• W4307038946 creator A5009273566 @default.
• W4307038946 creator A5011557750 @default.
• W4307038946 creator A5056710999 @default.
• W4307038946 creator A5071175870 @default.
• W4307038946 creator A5079805337 @default.
• W4307038946 creator A5081797454 @default.
• W4307038946 creator A5091458721 @default.
• W4307038946 date "2023-04-01" @default.
• W4307038946 modified "2023-09-23" @default.
• W4307038946 title "Reduction of donor mononuclear phagocytes with clodronate-liposome during ex vivo lung perfusion attenuates ischemia-reperfusion injury" @default.
• W4307038946 cites W1967131562 @default.
• W4307038946 cites W1994723172 @default.
• W4307038946 cites W2018406955 @default.
• W4307038946 cites W2022982231 @default.
• W4307038946 cites W2048379276 @default.
• W4307038946 cites W2055404740 @default.
• W4307038946 cites W2059287796 @default.
• W4307038946 cites W2065786649 @default.
• W4307038946 cites W2065840801 @default.
• W4307038946 cites W2081120686 @default.
• W4307038946 cites W2126767292 @default.
• W4307038946 cites W2149779111 @default.
• W4307038946 cites W2152469451 @default.
• W4307038946 cites W2153406260 @default.
• W4307038946 cites W2163590547 @default.
• W4307038946 cites W2166312049 @default.
• W4307038946 cites W2167527394 @default.
• W4307038946 cites W2167992469 @default.
• W4307038946 cites W2558760561 @default.
• W4307038946 cites W2587439456 @default.
• W4307038946 cites W2590917723 @default.
• W4307038946 cites W2604151315 @default.
• W4307038946 cites W2626232059 @default.
• W4307038946 cites W2786054755 @default.
• W4307038946 cites W2803146429 @default.
• W4307038946 cites W2924604097 @default.
• W4307038946 cites W3014810452 @default.
• W4307038946 cites W3038897260 @default.
• W4307038946 cites W3130796360 @default.
• W4307038946 cites W3160916547 @default.
• W4307038946 cites W3164572912 @default.
• W4307038946 cites W4200540588 @default.
• W4307038946 cites W4256005629 @default.
• W4307038946 doi "https://doi.org/10.1016/j.jtcvs.2022.10.022" @default.
• W4307038946 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36404143" @default.
• W4307038946 hasPublicationYear "2023" @default.
• W4307038946 type Work @default.
• W4307038946 citedByCount "0" @default.
• W4307038946 crossrefType "journal-article" @default.
• W4307038946 hasAuthorship W4307038946A5009273566 @default.
• W4307038946 hasAuthorship W4307038946A5011557750 @default.
• W4307038946 hasAuthorship W4307038946A5056710999 @default.
• W4307038946 hasAuthorship W4307038946A5071175870 @default.
• W4307038946 hasAuthorship W4307038946A5079805337 @default.
• W4307038946 hasAuthorship W4307038946A5081797454 @default.
• W4307038946 hasAuthorship W4307038946A5091458721 @default.
• W4307038946 hasConcept C126322002 @default.
• W4307038946 hasConcept C137061746 @default.
• W4307038946 hasConcept C142724271 @default.
• W4307038946 hasConcept C146957229 @default.
• W4307038946 hasConcept C150903083 @default.
• W4307038946 hasConcept C185592680 @default.
• W4307038946 hasConcept C202751555 @default.
• W4307038946 hasConcept C207001950 @default.
• W4307038946 hasConcept C26291073 @default.
• W4307038946 hasConcept C2777714996 @default.
• W4307038946 hasConcept C2780114680 @default.
• W4307038946 hasConcept C42219234 @default.
• W4307038946 hasConcept C541997718 @default.
• W4307038946 hasConcept C55493867 @default.
• W4307038946 hasConcept C71924100 @default.
• W4307038946 hasConcept C86803240 @default.
• W4307038946 hasConcept C98274493 @default.
• W4307038946 hasConceptScore W4307038946C126322002 @default.
• W4307038946 hasConceptScore W4307038946C137061746 @default.
• W4307038946 hasConceptScore W4307038946C142724271 @default.
• W4307038946 hasConceptScore W4307038946C146957229 @default.
• W4307038946 hasConceptScore W4307038946C150903083 @default.
• W4307038946 hasConceptScore W4307038946C185592680 @default.
• W4307038946 hasConceptScore W4307038946C202751555 @default.
• W4307038946 hasConceptScore W4307038946C207001950 @default.
• W4307038946 hasConceptScore W4307038946C26291073 @default.
• W4307038946 hasConceptScore W4307038946C2777714996 @default.
• W4307038946 hasConceptScore W4307038946C2780114680 @default.
• W4307038946 hasConceptScore W4307038946C42219234 @default.
• W4307038946 hasConceptScore W4307038946C541997718 @default.
• W4307038946 hasConceptScore W4307038946C55493867 @default.
• W4307038946 hasConceptScore W4307038946C71924100 @default.
• W4307038946 hasConceptScore W4307038946C86803240 @default.
• W4307038946 hasConceptScore W4307038946C98274493 @default.
• W4307038946 hasFunder F4320323365 @default.
• W4307038946 hasFunder F4320334764 @default.
• W4307038946 hasIssue "4" @default.
• W4307038946 hasLocation W43070389461 @default.
• W4307038946 hasLocation W43070389462 @default.
• W4307038946 hasOpenAccess W4307038946 @default.

• next